Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond

By Barton Hugh A   Lai Yurong   Goosen Theunis C   Jones Hannah M   El-Kattan Ayman F   Gosset James R   Lin Jian   Varma Manthena V  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite

Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions

By Kis Olena   Zastre Jason   Hoque Md.   Walmsley Sharon   Bendayan Reina  

Pharmaceutical Research, Vol. 30, Iss. 4, 2013-04 ,pp. : 1050-1064

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetic differences and drug–drug interactions in immunosuppressive therapy

By Warrington Jill S   Shaw Leslie M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 487-503

Informa Healthcare

Access to resources Recommend Favorite

The role of hepatic transporters in drug elimination

By Funk Christoph  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 4, 2008-04 ,pp. : 363-379

Informa Healthcare

Access to resources Recommend Favorite

Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination

By Smith Nicola F   Figg William D   Sparreboom Alex  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 429-445

Informa Healthcare

Access to resources Recommend Favorite